Zika Virus Found to Cause Testicular Atrophy in Mice

This article originally appeared here.
Share this content:
Zika Virus Found to Cause Testicular Atrophy in Mice
Zika Virus Found to Cause Testicular Atrophy in Mice

WEDNESDAY, Feb. 22, 2017 (HealthDay News) -- The Zika virus causes the testes of mice to shrink, according to an experimental study published in the Feb. 22 issue of Science Advances.

Because Zika can be transmitted through semen, researchers hypothesized that the virus might replicate in the testicles, lead author Ryuta Uraki, Ph.D., a postdoctoral associate with the Yale University School of Medicine in New Haven, Conn., told HealthDay. To test this, Uraki and his colleagues infected male mice with Zika and monitored the presence of the virus in different cell types.

The researchers found that even after Zika disappeared from the blood, the virus continued to replicate in Leydig cells. The researchers also found high levels of Zika genetic material in the epididymis. After 21 days, the testicles of Zika-infected mice had become significantly smaller than those of uninfected control mice, indicating progressive testicular atrophy. A reduction in serum testosterone was found to be the result of Zika infection, suggesting that male fertility can be affected.

"Our findings have important implications for nonvector-borne vertical transmission, as well as long-term potential reproductive deficiencies, in Zika virus-infected males," the authors write.

Abstract
Full Text

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Single-Payer Health System Bill Moves Forward in California

Single-Payer Health System Bill Moves Forward in California

Not yet clear where money for the single-payer system would come from

Regorafenib Approved for Hepatocellular Carcinoma

Regorafenib Approved for Hepatocellular Carcinoma

It is the first approved treatment for HCC in almost a decade

Three Anti-VEGF Treatments Effective for Diabetic Retinopathy

Three Anti-VEGF Treatments Effective for Diabetic Retinopathy

Rates of worsening low in patients receiving aflibercept, bevacizumab, or ranibizumab

is free, fast, and customized just for you!

Already a member?

Sign In Now »